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Silent information regulator 2 (Sir2) proteins, or sirtuins, are protein deacetylases/mono-ADP-ribosyltrans-
ferases found in organisms ranging from bacteria to humans. Their dependence on nicotinamide adenine
dinucleotide (NAD+) links their activity to cellular metabolic status. In bacteria, the sirtuin CobB regulates
the metabolic enzyme acetyl-coenzyme A (acetyl-CoA) synthetase. The earliest function of sirtuins therefore
may have been regulation of cellular metabolism in response to nutrient availability. Recent findings support
the idea that sirtuins play a pivotal role in metabolic control in higher organisms, including mammals. This
review surveys evidence for an emerging role of sirtuins as regulators of metabolism in mammals.Introduction
Calorie restriction (CR), a low-calorie dietary regimen without
malnutrition, extends the life span of yeast, worms, flies, and
mammals and decreases the incidence of age-associated disor-
ders such as cardiovascular disease, diabetes, and cancer in
animal models (Bordone and Guarente, 2005; Masoro, 2000).
In rodents, a 20%–40% reduction of calorie intake extends life
span by up to 50% (McCay et al., 1935; Pugh et al., 1999). While
the positive effects of CR in mammals have been known for de-
cades, the molecular mechanism of CR is not fully understood
(Koubova and Guarente, 2003).
Growing evidence suggests that a conserved family of pro-
teins, the sirtuins, mediate some of the beneficial effects of CR.
Named after the yeast silent information regulator 2 (Sir2), sirtuins
regulate important biological pathways in eubacteria, archaea,
and eukaryotes. Yeast Sir2 and some sirtuins are protein deace-
tylases (Imai et al., 2000; Landry et al., 2000; Smith et al., 2000).
Sirtuins mediate a deacetylation reaction that couples lysine
deacetylation to NAD+ hydrolysis. This hydrolysis yields O-ace-
tyl-ADP-ribose, the deacetylated substrate, and nicotinamide
(reviewed in Denu, 2005; Sauve et al., 2006). The dependence
of sirtuins on NAD+ suggests that their enzymatic activity is
directly linked to the energy status of the cell via the cellular
NAD+:NADH ratio; the absolute levels of NAD+, NADH, or nicotin-
amide; or a combination of these variables (Anderson et al., 2003;
Bitterman et al., 2002; Lin et al., 2000, 2002, 2004b).
Bacteria and archaea encode one or two sirtuins, while mice
and humans possess seven sirtuins (SIRT1–7) (see Table 1 for a
summary of the main properties of individual sirtuins). Mouse
and human sirtuins occupy several subcellular compartments,
such as the nucleus (SIRT1, 2, 3, 6, and 7), cytoplasm (SIRT1
and 2), and mitochondria (SIRT3, 4, and 5) (Blander and Guarente,
2004; Chen et al., 2006; Haigis et al., 2006; Michishita et al.,
2005; North and Verdin, 2004; Tanno et al., 2007; Scher et al.,
2007).
The sirtuins are assigned to five subclasses (I–IV and U) based
on the phylogenetic conservation of a core domain of250 amino
acids (Frye, 1999, 2000). Among mammalian sirtuins, SIRT1, 2,
and 3 are closely related class I sirtuins; show high homology to
104 Cell Metabolism 7, February 2008 ª2008 Elsevier Inc.the yeast sirtuins Sir2, Hst1, and Hst2; and exhibit robust deace-
tylase activity. SIRT4, a class II sirtuin, functions predominantly as
an ADP-ribosyltransferase (Haigis et al., 2006). Relatively little is
known about the enzymatic activities of SIRT5 (class III) and
SIRT6 and 7 (class IV).
In this review, we discuss what is currently known about the
regulation of metabolic functions by mammalian sirtuins, with
a particular emphasis on SIRT1, the most studied mammalian sir-
tuin. We review the role of SIRT1 in metabolic control in different
tissues and its possible role as a mediator of the physiological re-
sponse to CR. Three sirtuins, SIRT3, 4, and 5, are predominantly
localized in mitochondria, and their role in mitochondrial biology,
particularly metabolism, is also reviewed. Notably, SIRT1 and
SIRT3 are upregulated in response to CR. Sirtuins might therefore
participate in the homeostatic regulation of metabolism during
fasting and CR by regulating the acetylation level and activity of
key metabolic players. Finally, we discuss unresolved issues
and critical questions that remain to be addressed in this new
and exciting field of metabolic research.
Calorie Restriction, Aging, and Sirtuins
Given the conserved effect of CR on aging in most animal spe-
cies, there is considerable interest in identifying the cellular pro-
teins that mediate these beneficial effects. Are sirtuins mediators
of the mammalian CR response, and does CR extend the life
span of mammals in a sirtuin-dependent manner? Although
more experimental work will be needed to answer these ques-
tions, the available evidence suggests that sirtuins are part of
the pathway linking CR and life-span extension. Sirtuins have
been linked to CR in yeast, worms, and fruit flies (Kaeberlein
et al., 1999; Tissenbaum and Guarente, 2001; Wood et al.,
2004). In yeast and fruit flies, life-span extension through mod-
erate CR requires sirtuins (Lin et al., 2000, 2004b; Rogina and
Helfand, 2004) although this conclusion remains controversial
in yeast (reviewed in Guarente and Picard, 2005; Longo and
Kennedy, 2006).
CR promotes mitochondrial biogenesis and activates SIRT1
expression by increasing nitric oxide synthase (eNOS) expres-
sion (Nisoli et al., 2005). Interestingly, CR is associated with
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SIRT Class
Mouse Tissue
Expression (RNA)
Size
(kDa)
Subcellular
Localization Enzymatic Activity Targets
Resveratrol
Activation
1 I Ubiquitous;
low in liver
62 Cytoplasmic,
nuclear
(euchromatin)
Protein deacetylase PGC-1a, FOXO1,
FOXO3, NF-kB, AceCS1,
MEF2, PCAF, histones
H4K16 and H1K26, p53,
p300, MyoD, TAFI68,
HIV Tat protein
+
2 I Ubiquitous 41 Cytoplasmic, nuclear Protein deacetylase Tubulin, histone H4K16 
3 I Ubiquitous; high in
brain, kidney, brown
adipose tissue, testis,
heart, liver
28, 44a Mitochondrial,
nuclear
Protein deacetylase AceCS2, GDH 
4 II Muscle, kidney,
testis, liver
35 Mitochondrial ADP-ribosyltransferase GDH 
5 III Ubiquitous 34 Mitochondrial Low-activity protein
deacetylase
? 
6 IV Ubiquitous 39 Nuclear
(heterochromatin)
ADP-ribosyltransferase ? 
7 IV Brain, kidney, white
adipose tissue, liver, lung
45 Nucleolar ? ? 
a Mitochondrial form and nuclear form, respectively.increased physical activity in mice. However, this increase does
not occur in SIRT1 knockout mice subjected to CR, suggesting
that SIRT1 is required for at least some of the consequences
of CR (Chen et al., 2005). Other physiological changes induced
by CR, such as lower serum levels of glucose, triglycerides,
and insulin, occur normally in SIRT1 knockout mice, indicating
that these changes are mediated by other factors (Chen et al.,
2005). Recent work also indicates that SIRT1 transgenic mice
share a number of characteristics with mice under CR: they are
leaner and more metabolically active than littermate controls;
show reductions in blood cholesterol, insulin, and fasted glu-
cose; and perform better on a rotarod challenge (Bordone
et al., 2007).
Importantly, fasting and CR are not equivalent and induce only
partially overlapping physiological responses. For example,
acute starvation increases the NAD+:NADH ratio in liver, whereas
CR decreases it (Hagopian et al., 2003; Rodgers et al., 2005).
Consequently, short-term fasting and CR might have opposite
effects on some aspects of sirtuin function, and tissue-specific
differences may add further complexity.
Roles of Sirtuins in Mammalian Metabolism
Lipid Metabolism
In mammals, most energy is stored as fat in adipose tissues. Dur-
ing fasting, white adipose tissue (WAT) releases fatty acids that
are used as fuel by other organs. The transcription factor perox-
isome proliferator-activated receptor g (PPARg) regulates fat
storage by controlling the expression of key genes involved in
adipogenesis. SIRT1 modulates fat metabolism at several levels
(Figure 1). Overexpression of SIRT1 reduces fat accumulation
and the expression of genes encoding important fat-storage pro-
teins, such as adipose tissue-specific fatty acid-binding protein
(aP2), PPARg, CCAAT/enhancer-binding protein a (C/EBPa),
and C/EBPd (Picard et al., 2004).Mechanistically, SIRT1 represses transcription by docking
with the nuclear receptor corepressor (NCoR) and the silencing
mediator for retinoid and thyroid hormone receptor (SMRT).
The resulting SIRT1/NCoR/SMRT complex binds to DNA se-
quences referred to as PPARg response elements (PPREs) and
thereby represses the expression of PPARg target genes (Picard
et al., 2004). Interestingly, SIRT1 protein levels increase during
fasting and SIRT1 binds to and represses the aP2 promoter,
thereby promoting the release of fatty acids into the bloodstream
(Picard et al., 2004).
SIRT1 could also regulate fat metabolism in WAT through its
ability to interact withFOXO1, a transcription factor that represses
PPARg activity. Indeed, FOXO1 is reversibly deacetylated by
SIRT1 in the liver, leading to an increase in its activity (Dowell
et al., 2003; Frescas et al., 2005). The effect of SIRT1 on FOXO1
in adipose tissue has not yet been examined. Recent observa-
tions indicate that SIRT2, a predominantly cytoplasmic sirtuin
with specificity for acetylated a-tubulin (North et al., 2003), also
regulates the differentiation of adipocytes (Jing et al., 2007).
SIRT2 directly interacts with FOXO1, mediates its deacetylation,
and inhibits adipocyte differentiation. In contrast, SIRT2 knock-
down is associated with hyperacetylation, enhanced phosphory-
lation, cytosolic localization of FOXO1, and enhanced adipogen-
esis (Jing et al., 2007).
SIRT1 deacetylates the cytoplasmic enzyme acetyl-coenzyme
A (acetyl-CoA) synthetase 1 (AceCS1) (Hallows et al., 2006) (Fig-
ure 2). AceCS1 expression is regulated by sterol regulatory ele-
ment-binding proteins (SREBPs) and is increased by insulin
(Fujino et al., 2001; Luong et al., 2000; Sone et al., 2002). AceCS1
uses adenosine triphosphate (ATP) and acetate to produce ace-
tyl-CoA for the synthesis of fatty acids and cholesterol and is
expressed in all tissues. Deacetylation of AceCS1 by SIRT1
activates its acetyl-CoA synthetase activity, and overexpression
of SIRT1 increases fatty acid synthesis from acetate (Hallows
Cell Metabolism 7, February 2008 ª2008 Elsevier Inc. 105
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ReviewFigure 1. SIRT1 Regulates Metabolism in Multiple Tissues
SIRT1 regulates the activity of critical transcriptional regulators of metabolism, including FOXO1, PPARa, PPARg, and PGC-1a, in several organs. In the
liver, SIRT1 deacetylates and activates PGC-1a and interacts with FOXO1, which leads to activation of gluconeogenesis and decreased glycolysis. In muscle,
SIRT1 activates PGC-1a, inducing mitochondrial biogenesis and increasing fatty acid oxidation. In white adipose tissue (WAT), SIRT1 represses the transcrip-
tional activity of PPARg, causing increased fat mobilization and decreased adipogenesis. In the pancreas, SIRT1 enhances insulin secretion by downregulating
UCP2 expression. The expression and biological activity of SIRT1 are activated during fasting and calorie restriction (CR) and in response to resveratrol. It should
be noted that resveratrol has other cellular targets, such as AMPK, which could mediate some of its biological activities.et al., 2006). These findings might appear to contradict the ob-
servation that overexpression of SIRT1 reduces fat accumulation
as discussed above (Picard et al., 2004). However, in contrast to
SIRT1, which is induced during fasting, AceCS1 expression in
the liver is inhibited by fasting, as is hepatic fatty acid synthesis
(Sone et al., 2002). It is not entirely clear how SIRT1, a predomi-
nantly nuclear enzyme, regulates the activity of the cytoplasmic
AceCS1 protein. One possibility is that SIRT1 shuttles between
the nucleus and cytoplasm in certain cell types or under unique
physiological conditions (Moynihan et al., 2005; Tanno et al.,
2007).
Further support for a role of SIRT1 in lipolysis comes from ex-
periments with resveratrol, a polyphenolic compound isolated
from wine. Resveratrol functions in part as an allosteric activator
of SIRT1 in vitro (Howitz et al., 2003) and is associated with a de-
crease in WAT and smaller adipocytes in mice fed a high-fat diet
(Lagouge et al., 2006). However, it is likely that resveratrol acti-
vates other cellular targets in mammals beside SIRT1. Resvera-
trol also stimulates adenosine monophosphate (AMP) kinase
(AMPK) activity in neurons (Dasgupta and Milbrandt, 2007).
AMPK senses the cellular AMP:ATP ratio and is a critical regulator
of energy balance (Towler and Hardie, 2007; Kahn et al., 2005).
Activation of AMPK inhibits hepatic fatty acid production and
increases fatty acid oxidation in skeletal muscle (Towler and Har-
die, 2007; Kahn et al., 2005). Therefore, direct activation of AMPK
by resveratrol could account for some of its beneficial effects in
mice on high-fat diets (Baur et al., 2006; Lagouge et al., 2006).
Further studies in SIRT1-deficient mice are needed to address
whether the effects observed in vivo are mediated by direct—or
106 Cell Metabolism 7, February 2008 ª2008 Elsevier Inc.possibly indirect—activation of SIRT1. Ideally, such studies
would be performed in SIRT1 knockin mice carrying the E230K
mutation, which abolishes resveratrol-mediated SIRT1 activation
(Baur and Sinclair, 2006).
Nevertheless, SIRT1 clearly has a role in regulating lipid metab-
olism, and SIRT1 overexpression or activation could be protec-
tive against diet-induced obesity. Since germline deletion of
both SIRT1 alleles in mice has pleiotropic effects, studies of
mice with conditional and tissue-specific deletions of the SIRT1
gene will be critical to resolve these questions.
Liver and Muscle Metabolism
Production of three-carbon substrates for gluconeogenesis by
the fasting liver is the most important source of glucose produc-
tion in higher organisms and provides other organs with energy
during fasting. The PPARg coactivator-1a (PGC-1a) coactivates
the transcription factors HNF-4a and FOXO1 to drive the expres-
sion of genes involved in gluconeogenesis. Importantly, SIRT1
protein levels increase in the liver and muscle of fasted mice (Ger-
hart-Hines et al., 2007; Rodgers et al., 2005). Furthermore, SIRT1
deacetylates and activates PGC-1a in liver cells, resulting in the
upregulation of gluconeogenic pathways and downregulation of
glycolytic pathways (Rodgers et al., 2005) (Figure 1). In hepato-
cytes, SIRT1 also activates FOXO1 directly to shift glucose me-
tabolism to gluconeogenesis, thereby promoting the release of
glucose (Frescas et al., 2005). Activation of PGC-1a by SIRT1
via its deacetylation could also enhance the expression of PPARa
target genes that are involved in fatty acid oxidation by the liver.
Knockdown of SIRT1 in liver causes mild hypoglycemia, de-
creased hepatic glucose output, decreased serum cholesterol,
Cell Metabolism
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Cytoplasmic and Mitochondrial Acetyl-CoA
Synthetases
SIRT1 and SIRT3 deacetylate and activate the cyto-
plasmic and mitochondrial acetyl-CoA synthetases 1
and 2 (AceCS1 and AceCS2), respectively. Both cyto-
plasmic and mitochondrial acetyl-CoA synthetase
enzymes are enzymatically inactive when acetylated.
Deacetylation of cytoplasmic AceCS1 by SIRT1
activates the enzyme, which utilizes adenosine tri-
phosphate (ATP), acetate, and coenzyme A (CoA) to
generate increased levels of acetyl-CoA. Adenosine
monophosphate (AMP) and inorganic phosphate
(PPi) are generated as byproducts of this enzymatic
reaction. The cytoplasmic acetyl-CoA can be used to
make lipids for energy storage and serves as an impor-
tant acetyl donor for histone acetyltransferases
(HATs). Activation of mitochondrial AceCS2 leads to
an increase in mitochondrial acetyl-CoA, which can
be used either by the tricarboxylic acid (TCA) cycle
for energy generation or for the synthesis of ketone
bodies.
Insulin Secretion, Insulin Signaling,
and Glucose Metabolism
Mice specifically overexpressing SIRT1 in
pancreatic b cells show improved glucose
tolerance due to increased glucose-stimu-
lated insulin secretion and reduced expres-
sion of uncoupling protein 2 (UCP2) (Moyni-
han et al., 2005). SIRT1 directly binds to
and represses the UCP2 promoter, and
SIRT1 knockout mice have constitutivelyolism 7, February 2008 ª2008 Elsevier Inc. 107and increased hepatic free fatty acids (Rodgers and Puigserver,
2007). These changes are tightly correlated with decreased ex-
pression of gluconeogenic, fatty acid oxidation, and cholesterol
degradation genes (Rodgers and Puigserver, 2007).
PGC-1a also controls important processes such as mitochon-
drial biogenesis in adipose tissue and skeletal muscle (Lin et al.,
2004a; Puigserver et al., 1998). Both short-term exercise and en-
durance training enhance PGC-1a expression in skeletal muscle.
In transgenic mice, overexpression of PGC-1a in muscle is asso-
ciated with an increased proportion of oxidative type I muscle
fibers and resistance to fatigue, consistent with the notion that
PGC-1a expression is sufficient to drive the slow-twitch muscle
differentiation program. Remarkably, treatment of mice with
resveratrol increases mitochondrial biogenesis and oxidative ca-
pacity in muscle and decreases PGC-1a acetylation, consistent
with SIRT1 activation (Lagouge et al., 2006) (Figure 1). PGC-1a
also regulates fuel utilization in muscle cells by increasing fatty
acid oxidation and shutting down glucose oxidation. Under
low-glucose conditions, SIRT1 is required to activate fatty acid
oxidation in skeletal muscle (Gerhart-Hines et al., 2007). Mecha-
nistically, SIRT1 accomplishes this by deacetylating and thereby
activating PGC-1a at promoter regions of genes involved in mi-
tochondrial respiration and fatty acid oxidation (Gerhart-Hines
et al., 2007). While many SIRT1 substrates are also targeted by
other deacetylases, SIRT1 is the main PGC-1a deacetylase (Ger-
hart-Hines et al., 2007). Overall, these findings suggest that
SIRT1 function is necessary to upregulate fatty acid consump-
tion in skeletal muscle in response to low-glucose conditions.high UCP2 expression (Bordone and Guarente, 2005). Uncou-
pling proteins are found in the inner mitochondrial membrane,
where they cause a proton leak that uncouples oxygen con-
sumption from ATP generation during oxidative phosphorylation.
Insulin secretion from pancreatic b cells is intimately connected
to the intracellular ATP:ADP ratio, and therefore to ATP produc-
tion, by oxidative phosphorylation. Mice that overexpress SIRT1
in b cells have higher b cell ATP levels in response to glucose
stimulation, most likely as a result of reduced UCP2 expression,
and show enhanced insulin secretion (Moynihan et al., 2005).
Conversely, reduction of SIRT1 expression in b cell lines by
siRNA induces UCP2 protein levels and reduces insulin secretion
(Bordone et al., 2006).
SIRT1 also regulates p53, Ku70, NF-kB, PPARg, FOXO1, PGC-
1a, and p300, all of which have roles in regulating gene expres-
sion in b cells. Therefore, regulation of insulin secretion from
b cells by SIRT1 is probably not limited to its effects on UCP2
expression. For instance, SIRT1 protects pancreatic b cells
from acute oxidative stress by deacetylating FOXO1 (Kitamura
et al., 2005). It will be interesting to see whether mice overex-
pressing SIRT1 in b cells are protected against aging-induced
loss of b cells and decreases in b cell function.
Insulin regulates glucose levels in plasma and tissues by induc-
ing the selective uptake of glucose across the plasma membrane.
Type II diabetes is associated with decreased responsiveness of
peripheral tissues to insulin, resulting in increased blood glucose
levels and a compensatory increase in insulin levels. Interestingly,
resveratrol treatment of mice on a high-fat diet improves their
Cell Metabolism
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sponse to a given amount of insulin after resveratrol treatment
(Baur et al., 2006; Lagouge et al., 2006). A recent report indicates
that SIRT1 is downregulated in insulin-resistant tissues and that
knockdown or inhibition of SIRT1 induces insulin resistance
(Sun et al., 2007). Remarkably, increasing SIRT1 expression or
SIRT1 activation by resveratrol improves insulin sensitivity, espe-
cially under conditions of insulin resistance (Sun et al., 2007). The
effect of SIRT1 on insulin resistance appears to be mediated at
least in part via repression of protein tyrosine phosphatase 1B
(PTP1B), a known negative regulator of the insulin signaling cas-
cade (Sun et al., 2007).
Sirtuins also regulate glucose metabolism via PGC-1a. Hepatic
PGC-1a activity is enhanced in diabetic mice and could contrib-
ute to the enhanced hepatic glucose output associated with dia-
betes. Hepatic SIRT1 induces gluconeogenic genes and glucose
output by deacetylating and activating PGC-1a (Rodgers et al.,
2005). Further activation of SIRT1 in the liver of patients with dia-
betes might therefore not be desirable. In contrast, overexpres-
sion of PGC-1a in muscle protects against obesity and insulin
resistance induced by a high-fat diet. Thus, muscle-specific
SIRT1 activation might exhibit antidiabetic activities.
Mitochondrial Sirtuins
As discussed above, three sirtuins, SIRT3, 4, and 5, are located
in the mitochondria (Lombard et al., 2007; Haigis et al., 2006;
Michishita et al., 2005; Onyango et al., 2002; Schwer et al.,
2002). Endogenous SIRT3 is a soluble protein in the mitochon-
drial matrix (Schwer et al., 2002, 2006). A small fraction of
full-length, unprocessed human SIRT3 has been suggested to
localize to the nucleus; however, its biological relevance in this
subcellular compartment has not been established (Scher
et al., 2007). A role has been proposed for SIRT3 in the control
of adaptive thermogenesis via its activity in brown adipose tissue
(BAT). BAT harbors large numbers of mitochondria and is impor-
tant for thermogenesis in rodents. Thermogenesis in BAT is me-
diated by UCP1, which induces proton leakage at the inner mito-
chondrial membrane, thereby generating heat instead of ATP.
SIRT3 expression in BAT is activated by CR and exposure to
cold (Shi et al., 2005). Overexpression of SIRT3 in HIB1B brown
adipocytes increases the expression of PGC-1a and UCP1 (Shi
et al., 2005). However, the relevance of these observations in
vivo is not known at present.
Aside from controlling metabolism at the transcriptional level,
sirtuins directly control the activity of metabolic enzymes. In Sal-
monella enterica, the bacterial sirtuin CobB regulates the activity
of the enzyme acetyl-CoA synthetase (Starai et al., 2002). Acetyl-
CoA synthetase mediates the synthesis of acetyl-CoA from ATP
and acetate. This reaction enables bacteria to grow on acetate
and to utilize acetate for acetyl-CoA synthesis (reviewed in
Wolfe, 2005).
Orthologs of bacterial acetyl-CoA synthetase exist in the cyto-
plasm (AceCS1) and in the mitochondria (AceCS2) in mammals
(Fujino et al., 2001; Luong et al., 2000). SIRT3 and AceCS2 inter-
act within mitochondria, where SIRT3 deacetylates a single res-
idue in AceCS2 (K642) and activates its enzymatic activity
(Hallows et al., 2006; Schwer et al., 2006) (Figure 2).
Under ketogenic conditions, such as long-term fasting or dia-
betes, the mammalian liver releases substantial amounts of ace-108 Cell Metabolism 7, February 2008 ª2008 Elsevier Inc.tate into the bloodstream (Buckley and Williamson, 1977; Seufert
et al., 1974; Yamashita et al., 2001), at least in part via the acti-
vation of acetyl-CoA hydrolase (Matsunaga et al., 1985). This
released acetate must be activated before it can be utilized
for metabolism. Mitochondrial AceCS2 is expressed in heart,
muscle, brain, and kidney, but not in liver (Fujino et al., 2001),
and allows these organs to convert the released acetate into
acetyl-CoA.
The cytoplasmic (AceCS1) and mitochondrial (AceCS2) ace-
tyl-CoA synthetases are differentially regulated: fasting induces
AceCS2 expression (Fujino et al., 2001), while fasting decreases
AceCS1 expression in the liver and in other tissues (Fujino et al.,
2001; Sone et al., 2002). These observations point to an interest-
ing possibility: under fasting and ketogenic conditions, acetate
could be released from the liver and utilized by AceCS2 in extra-
hepatic tissues (Fujino et al., 2001). By activating AceCS2, SIRT3
controls the entry of acetate into the tricarboxylic acid (TCA)
cycle in the form of acetyl-CoA, where it can be used for energy
production.
In yeast, acetyl-CoA synthetase activity in the nucleus and cy-
tosol is important for histone acetylation by providing a steady
supply of acetyl-CoA to the histone acetyltransferases (HATs)
(Takahashi et al., 2006). AceCS2 activity might play a similar
role in the mitochondria and provide acetyl-CoA to a putative
mitochondrial protein acetyltransferase, thereby regulating the
acetylation status of mitochondrial proteins. The AceCS2 reac-
tion also yields AMP. It will be important to investigate whether
AceCS2 activation by SIRT3 changes the intramitochondrial
acetyl-CoA:CoA and AMP:ATP ratios, which might have implica-
tions for the regulation of other mitochondrial metabolic path-
ways, such as the pyruvate dehydrogenase complex.
AceCS2 is the first identified mitochondrial protein controlled
by reversible lysine acetylation and the first target for a mitochon-
drial sirtuin deacetylase. However, a recent report showed that
a large number of mitochondrial proteins are subject to revers-
ible lysine acetylation (Kim et al., 2006). It will be important to
investigate which of these proteins are substrates for SIRT3 or
other mitochondrial sirtuins.
The expression of SIRT3 appears to be responsive to the
metabolic dysregulation associated with diabetes (Yechoor
et al., 2004). In streptozotocin-induced diabetes in mice, SIRT3
mRNA expression is strongly downregulated (Yechoor et al.,
2004). Interestingly, SIRT3 expression is not modified in mice
lacking a functional insulin receptor in muscle, indicating that
lack of insulin action itself is not responsible for the downregula-
tion of SIRT3 expression (Yechoor et al., 2004).
Recent experiments indicate that mice lacking both SIRT3
alleles exhibit a striking hyperacetylation of mitochondrial pro-
teins. In contrast, mice knocked out for either SIRT4 or SIRT5
show no change in mitochondrial protein acetylation (Lombard
et al., 2007). These observations suggest that SIRT3 is a major
mitochondrial deacetylase. Surprisingly, despite this biochem-
ical phenotype, SIRT3-deficient mice are metabolically unre-
markable under basal conditions (Lombard et al., 2007).
SIRT4 is also involved in the regulation of mitochondrial energy
metabolism. Unlike SIRT3, SIRT4 lacks detectable deacetylase
activity (Ahuja et al., 2007; Haigis et al., 2006; North et al.,
2003); however, it exhibits mono-ADP-ribosyltransferase activity
in vitro (Ahuja et al., 2007; Haigis et al., 2006). SIRT4 mediates the
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Glucose is taken up by b cells via glucose transporter 2 (GLUT2), and its oxidation generates ATP. The resulting increase in the ATP:ADP ratio closes KATP chan-
nels, leading to the depolarization of the plasma membrane and the opening of voltage-gated Ca2+ channels. The intracellular influx of calcium leads to insulin
secretion. Insulin stimulation can also be activated by glutamine, which is metabolized via the TCA cycle and also contributes to increasing the ATP:ADP ratio.
SIRT1 represses the expression of the uncoupling protein UCP2 by binding directly to the UCP2 promoter. UCP2 allows proton leakage across the inner mito-
chondrial membrane and uncouples oxygen consumption from ATP production during respiration. Decreased UCP2 is associated with higher ATP levels and
increased insulin secretion in response to glucose. In contrast, loss of SIRT1 is associated with increased UCP2 expression and a blunted insulin response to
glucose. SIRT4 is present in pancreatic b cell mitochondria, where it inhibits glutamate dehydrogenase (GDH) via ADP-ribosylation and consequently reduces
amino acid-induced insulin secretion. GDH is a rate-limiting enzyme in the metabolism of glutamate in b cells. SIRT4 also interacts with the adenine nucleotide
transporters ANT2 and 3 and may regulate insulin secretion via ATP/ADP transport in and out of the mitochondria.ADP-ribosylation of glutamate dehydrogenase (GDH), leading to
an inhibition of its enzymatic activity (Haigis et al., 2006) (Figure 3).
GDH converts glutamate into a-ketoglutarate, which can be used
as fuel in the TCA cycle, and thereby regulates amino acid-stim-
ulated insulin secretion. The TCA cycle connects the nutritional
status of b cells to insulin secretion. Both glucose and amino
acids increase TCA cycle flux, which results in increased ATP
levels, increased ATP:ADP ratio, subsequent closure of ATP-
dependent K+ channels, opening of voltage-gated calcium chan-
nels, and promotion of insulin exocytosis (Figure 3). Knockout of
SIRT4 via siRNA in insulin-producing INS-1E cells is associated
with enhanced insulin secretion, while overexpression of SIRT4
inhibits insulin secretion in the same system (Ahuja et al., 2007).
SIRT4 knockout mice, which exhibit lower levels of ADP-ribosy-
lated GDH, display higher GDH activity and increased amino
acid-stimulated insulin secretion (Haigis et al., 2006).
SIRT4 activity appears to be downregulated in b cells during
CR, and isolated pancreatic islets from mice on CR exhibit in-
creased amino acid-stimulated insulin secretion (Haigis et al.,
2006). This is in contrast to SIRT1 and SIRT3, whose expression
is enhanced during CR. SIRT4 is widely expressed and thus is
likely to have roles in organs other than the pancreas. In the liver,
GDH contributes significantly to the regulation of gluconeogen-
esis and is activated during CR (Hagopian et al., 2003). This in-crease in GDH activity during CR may be due to a reduction in
GDH ADP-ribosylation caused by a reduction in SIRT4 activity.
SIRT4 also interacts with two other mitochondrial proteins, the
adenine nucleotide transporters ANT2 and 3, and a mitochondrial
protease called insulin-degrading enzyme (IDE) (Ahuja et al.,
2007). The physiological relevance of these interactions has
not been determined.
SIRT5, another mitochondrial protein (Lombard et al., 2007;
Michishita et al., 2005), shows low-level deacetylase activity on
chemically acetylated histone peptides in vitro and lacks ADP-ri-
bosyltransferase activity (Haigis et al., 2006; North et al., 2003).
No target or biological function has been assigned to SIRT5,
making it an important subject for future studies.
SIRT1 also influences mitochondrial function, although indi-
rectly, by regulating PGC-1a, a factor that controls mitochondrial
biogenesis in adipose tissue and skeletal muscle (Lin et al.,
2004a; Puigserver et al., 1998). Mice treated with resveratrol ex-
hibit increased mitochondrial biogenesis, increased oxidative
capacity in muscle, and decreased PGC-1a acetylation, consis-
tent with SIRT1 activation (Lagouge et al., 2006).
Conclusions and Future Directions
Do mammalian sirtuins extend life span by modulating metabo-
lism? Longevity-promoting effects are expected based on theCell Metabolism 7, February 2008 ª2008 Elsevier Inc. 109
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Reviewdocumented ability of SIRT1 to modulate insulin/IGF-1 signaling,
a critical pathway in aging (Guarente and Kenyon, 2000; Nemoto
and Finkel, 2002). Interestingly, mice lacking SIRT6 exhibit a dra-
matic metabolic phenotype. Three-week-old SIRT6 knockout
mice exhibit acute loss of subcutaneous fat and die within one
week, most likely from hypoglycemia (Mostoslavsky et al.,
2006). These mice also exhibit low IGF-1 levels that precede
the onset of the acute loss of subcutaneous fat. Thus, SIRT6
function also appears to be required for normal glucose and
IGF-1 levels.
In mammals, CR increases SIRT1 and SIRT3 protein levels
(Cohen et al., 2004; Nemoto et al., 2004; Rodgers et al., 2005;
Shi et al., 2005), consistent with the model that these enzymes
mediate some of the metabolic changes associated with CR.
Studies addressing the roles of sirtuins in the metabolism of
postmitotic tissues, such as heart and brain, are crucial because
increased sirtuin activity might prevent age-related degeneration
and loss of function in these tissues. Also, further studies are
needed to delineate the possible differences between acute
starvation and long-term CR in terms of enzymatic activity and
expression levels of sirtuins in different tissues.
A better understanding of the factors controlling sirtuin function
is needed. Specifically, further insight is needed on how NAD+,
NADH, and nicotinamide levels fluctuate under various metabolic
conditions in different tissues. A recent thought-provoking report
shows that the NAD+-precursor nicotinamide riboside elevates
NAD+ levels, increases Sir2 function, and prolongs life span in
yeast (Belenky et al., 2007). These findings could have important
implications for mammalian sirtuin biology and for the activation
of mammalian sirtuins in vivo. Another recent report demon-
strates that nicotinamide phosphoribosyltransferase (Nampt),
which catalyzes the first and rate-limiting step in NAD+ synthesis
from nicotinamide, is induced by cell stress and nutrient restric-
tion (Yang et al., 2007). Increased Nampt leads to increased
mitochondrial NAD+, which protects against cell death. Impor-
tantly, SIRT3 and SIRT4 are required for the Nampt-mediated
protection against genotoxic stress. A central role for mitochon-
dria in aging has been suggested (Wallace, 2005), and it will there-
fore be exciting to see whether the mitochondrial sirtuins affect
mammalian aging.
In this review, we have discussed the involvement of sirtuins in
the regulation of metabolism. Studies in lower organisms imply
the existence of a genetic program that mediates the extension
of life span by CR. Mammalian sirtuins are likely to be important
players in the CR response and in the regulation of metabolism,
but much more experimental work is required before such an in-
volvement can be fully evaluated. Along the way, the quest for
a better understanding of mammalian sirtuin biology is likely to
yield valuable new approaches for the treatment and prevention
of metabolic diseases.
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